Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. In 2015 we invested a total of €4.3 billion in research and development. This figure – up 21 percent on the previous year and equivalent to 9.1 percent of sales – represents a sound platform to introduce further innovative products in expanding life science markets.
Bayer holds a worldwide leading position in its main therapeutic areas and our Pharmaceuticals portfolio focuses on:
General Medicine & Specialty Medicine - General Medicines consists of prescription products, especially for cardiology and women’s health, whilst Specialty Medicines covers the areas of haematology, neurology, oncology and ophthalmology.
Radiology - combines contrast-enhanced diagnostic imaging equipment and the necessary contrast agents into a single source for radiology and equipment support services.
Diabetes Care - a global leader in the field of blood glucose monitoring systems, providing devices and test strips for more than 40 years. These products are used by those with diabetes to safely and conveniently monitor their blood glucose levels both at home and on the move.